Figure 1. Mean weekly dosages in open-label extension (OLE) study based on responder group in lead-in study.
OLE is OV-1004 (NCT01160770).18 Lead-in refers to study OV-1012 (NCT00518713).17
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.